vs

Side-by-side financial comparison of Armour Residential REIT, Inc. (ARR) and Schrodinger, Inc. (SDGR). Click either name above to swap in a different company.

Schrodinger, Inc. is the larger business by last-quarter revenue ($87.2M vs $50.4M, roughly 1.7× Armour Residential REIT, Inc.). Armour Residential REIT, Inc. runs the higher net margin — 420.2% vs 37.3%, a 383.0% gap on every dollar of revenue. On growth, Armour Residential REIT, Inc. posted the faster year-over-year revenue change (297.9% vs -1.2%). Over the past eight quarters, Armour Residential REIT, Inc.'s revenue compounded faster (108.0% CAGR vs 54.4%).

Armour Residential REIT, Inc. is a U.S.-based real estate investment trust that primarily invests in agency residential mortgage-backed securities guaranteed by U.S. government-sponsored entities. It focuses on generating consistent long-term net income for shareholders via strategic asset management and active interest rate risk mitigation.

Schrodinger, Inc. is a leading provider of advanced computational chemistry and physics software platforms, along with related consulting services, focused on accelerating drug discovery and novel materials development. Its solutions are adopted by biopharmaceutical companies, chemical manufacturers, academic research institutions and government entities across North America, Europe and Asia Pacific to cut R&D costs and shorten innovation cycles.

ARR vs SDGR — Head-to-Head

Bigger by revenue
SDGR
SDGR
1.7× larger
SDGR
$87.2M
$50.4M
ARR
Growing faster (revenue YoY)
ARR
ARR
+299.1% gap
ARR
297.9%
-1.2%
SDGR
Higher net margin
ARR
ARR
383.0% more per $
ARR
420.2%
37.3%
SDGR
Faster 2-yr revenue CAGR
ARR
ARR
Annualised
ARR
108.0%
54.4%
SDGR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARR
ARR
SDGR
SDGR
Revenue
$50.4M
$87.2M
Net Profit
$211.7M
$32.5M
Gross Margin
65.7%
Operating Margin
-19.7%
Net Margin
420.2%
37.3%
Revenue YoY
297.9%
-1.2%
Net Profit YoY
555.9%
180.8%
EPS (diluted)
$2.43
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARR
ARR
SDGR
SDGR
Q4 25
$50.4M
$87.2M
Q3 25
$38.5M
$54.3M
Q2 25
$33.1M
$54.8M
Q1 25
$36.3M
$59.6M
Q4 24
$12.7M
$88.3M
Q3 24
$35.3M
Q2 24
$7.0M
$47.3M
Q1 24
$36.6M
Net Profit
ARR
ARR
SDGR
SDGR
Q4 25
$211.7M
$32.5M
Q3 25
$159.3M
$-32.8M
Q2 25
$-75.6M
$-43.2M
Q1 25
$27.3M
$-59.8M
Q4 24
$-46.4M
$-40.2M
Q3 24
$-38.1M
Q2 24
$-48.4M
$-54.0M
Q1 24
$-54.7M
Gross Margin
ARR
ARR
SDGR
SDGR
Q4 25
65.7%
Q3 25
51.6%
Q2 25
47.8%
Q1 25
52.3%
Q4 24
72.6%
Q3 24
50.2%
Q2 24
66.2%
Q1 24
51.6%
Operating Margin
ARR
ARR
SDGR
SDGR
Q4 25
-19.7%
Q3 25
-84.6%
Q2 25
-96.6%
Q1 25
-85.5%
Q4 24
-23.5%
Q3 24
-193.9%
Q2 24
-111.4%
Q1 24
-184.3%
Net Margin
ARR
ARR
SDGR
SDGR
Q4 25
420.2%
37.3%
Q3 25
413.5%
-60.4%
Q2 25
-228.4%
-78.8%
Q1 25
75.2%
-100.4%
Q4 24
-366.8%
-45.5%
Q3 24
-108.1%
Q2 24
-693.8%
-114.2%
Q1 24
-149.5%
EPS (diluted)
ARR
ARR
SDGR
SDGR
Q4 25
$2.43
$0.45
Q3 25
$1.49
$-0.45
Q2 25
$-0.94
$-0.59
Q1 25
$0.32
$-0.82
Q4 24
$-0.91
$-0.55
Q3 24
$-0.52
Q2 24
$-1.05
$-0.74
Q1 24
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARR
ARR
SDGR
SDGR
Cash + ST InvestmentsLiquidity on hand
$63.3M
$395.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.3B
$364.1M
Total Assets
$21.0B
$726.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARR
ARR
SDGR
SDGR
Q4 25
$63.3M
$395.5M
Q3 25
$44.2M
$391.2M
Q2 25
$141.2M
$450.2M
Q1 25
$49.1M
$500.3M
Q4 24
$68.0M
$352.1M
Q3 24
$388.7M
Q2 24
$126.6M
$377.3M
Q1 24
$431.1M
Stockholders' Equity
ARR
ARR
SDGR
SDGR
Q4 25
$2.3B
$364.1M
Q3 25
$2.1B
$321.4M
Q2 25
$1.7B
$342.9M
Q1 25
$1.7B
$373.5M
Q4 24
$1.4B
$421.4M
Q3 24
$449.4M
Q2 24
$1.2B
$474.0M
Q1 24
$513.7M
Total Assets
ARR
ARR
SDGR
SDGR
Q4 25
$21.0B
$726.2M
Q3 25
$19.4B
$653.7M
Q2 25
$16.2B
$688.2M
Q1 25
$15.5B
$743.0M
Q4 24
$13.5B
$823.2M
Q3 24
$669.3M
Q2 24
$10.1B
$688.4M
Q1 24
$737.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARR
ARR
SDGR
SDGR
Operating Cash FlowLast quarter
$124.2M
$-16.1M
Free Cash FlowOCF − Capex
$-16.1M
FCF MarginFCF / Revenue
-18.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
0.59×
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARR
ARR
SDGR
SDGR
Q4 25
$124.2M
$-16.1M
Q3 25
$-37.8M
$-61.9M
Q2 25
$25.0M
$-52.2M
Q1 25
$101.5M
$144.1M
Q4 24
$261.5M
$-31.1M
Q3 24
$-33.3M
Q2 24
$27.1M
$-53.7M
Q1 24
$-39.3M
Free Cash Flow
ARR
ARR
SDGR
SDGR
Q4 25
$-16.1M
Q3 25
$-62.4M
Q2 25
$-52.5M
Q1 25
$143.5M
Q4 24
$-32.0M
Q3 24
$-34.6M
Q2 24
$-54.7M
Q1 24
$-43.4M
FCF Margin
ARR
ARR
SDGR
SDGR
Q4 25
-18.5%
Q3 25
-114.8%
Q2 25
-95.9%
Q1 25
240.9%
Q4 24
-36.2%
Q3 24
-98.0%
Q2 24
-115.6%
Q1 24
-118.5%
Capex Intensity
ARR
ARR
SDGR
SDGR
Q4 25
0.0%
Q3 25
0.9%
Q2 25
0.6%
Q1 25
1.0%
Q4 24
1.0%
Q3 24
3.8%
Q2 24
2.1%
Q1 24
11.2%
Cash Conversion
ARR
ARR
SDGR
SDGR
Q4 25
0.59×
-0.50×
Q3 25
-0.24×
Q2 25
Q1 25
3.71×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARR
ARR

Segment breakdown not available.

SDGR
SDGR

On Premise Software$44.4M51%
Drug Discovery Services$17.6M20%
Hosted Software$11.5M13%
Maintenance$6.9M8%
Professional Services$3.8M4%
July2024Agreement With Bill Melinda Gates Foundation$2.7M3%

Related Comparisons